Five USANA Country/Region Markets Recognized for Product Excellence by Euromonitor International
USANA Malaysia, Philippines, Singapore, Taiwan, and Hong Kong all awarded KUALA LUMPUR, Malaysia, Feb. 15, 2025 /PRNewswire/ -- Five of USANA Health Sciences' Asia Pacific markets were recently awarded by the prestigious Euromonitor International. These distinctions are based on Euromonitor's market research of USANA's retail value share among all supplement brands in...
Telix Announces Executive Leadership Appointments
MELBOURNE, Australia, Dec. 5, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces several key executive leadership appointments and promotions, reflecting the increased commercial focus of the Company and ongoing succession planning. Richard Valeix promoted to Group Chief Commercial Officer Richard Valeix, who has been in the role...
Connected pen injector add-on designed by SHL Medical wins 2021 Good Design Award
ZUG, Switzerland, Feb. 24, 2022 /PRNewswire/ -- SHL Medical and Innovation Zed is pleased to share the news that Innovation Zed's injection time-tracker connected device, the InsulCheck CONNECT, a device that was designed by SHL Medical, has been selected as a winner of the 2021 Good Design Award. InsulCheck CONNECT by Innovation Zed, designed...
Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma
EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6. The Fast Track Designation highlights the potential of EBC-129 to address critical unmet needs in pancreatic ductal adenocarcinoma (PDAC). Updated clinical data from the...
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Collaboration will harness Medidata Electronic Clinical Outcome Assessment (eCOA) for remote patient engagement and real-time data capture SINGAPORE, Feb. 29, 2024 /PRNewswire/ -- Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, and Sanofi Vaccines, today announced a collaboration to harness Medidata eCOA to deploy in vaccine studies. This builds...
FIRST CLINICAL EVIDENCE PUBLISHED ON AROA’s ENIVO™ SYSTEM FOR SURGICAL DEAD SPACE MANAGEMENT.
AUCKLAND, New Zealand, Aug. 27, 2025 /PRNewswire/ -- AROA is pleased to announce the findings of the first in human study involving its new ENIVO platform technology. The study is the subject of a peer-reviewed publication entitled Prospective, First-in-Human Clinical Evaluation of a Novel Tissue Apposition Device (ENIVO™) Following Simple Unilateral Mastectomy, which was published in the well-respected journal, Plastic and...
Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement
FORT MILL, S.C., Sept. 6, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China, and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ: XFIN), a publicly traded special purpose acquisition company, today announced that Baird Medical Investment Holdings Limited's ("PubCo") registration statement on Form F-4 (the "Registration...
Servier receives a positive CHMP opinion for Tibsovo® in IDH1-mutated Acute Myeloid Leukemia (AML) and Cholangiocarcinoma (CCA) patients
Tibsovo® (ivosidenib tablets) is the first IDH1 inhibitor recommended for approval in Europe The positive CHMP opinion is based on clinical data from the AGILE (in AML) and ClarIDHy (in CCA) studies PARIS, Feb. 24, 2023 /PRNewswire/ -- Servier, a global pharmaceutical company, today announced that the Committee for Medicinal...
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
HONG KONG, Oct. 15, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced that Tencent has made a strategic US$30 million investment in Insighta, a Hong Kong-based early cancer detection company. This investment values Insighta at US$200 million and underscores Tencent's endeavor to advancing AI-powered innovations in healthcare. Following the transaction, Prenetics' stake in...
PANTAI HOSPITAL KUALA LUMPUR RECOGNISED AS ASIA’S TOP PRIVATE HOSPITAL FOR 2025 BY NEWSWEEK
KUALA LUMPUR, Malaysia, Jan. 24, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) is proud to announce its recognition as Asia's Top Private Hospital for 2025, awarded by Newsweek in collaboration with Statista. This accolade underscores PHKL's unwavering dedication to delivering world-class healthcare, pioneering medical advancements, and exceptional patient care. Pantai Hospital Kuala Lumpur...
